Zahra Jawad - tumour antibody penetration

Dr. Zahra Jawad, founder and CEO of Creasallis, discusses antibody engineering and innovation to improve antibody penetration of solid tumours. 

The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a focus on genomics.

https://www.bioinformaticscro.com/